Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hdx
|
ENSMUSG00000034551.6 | highly divergent homeobox |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_111696421_111696641 | Hdx | 548 | 0.849892 | 0.77 | 8.1e-12 | Click! |
chrX_111696678_111697295 | Hdx | 93 | 0.982176 | 0.71 | 9.8e-10 | Click! |
chrX_111660518_111660669 | Hdx | 36486 | 0.196598 | 0.68 | 1.4e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_22794374_22794759 | 17.26 |
Gm25942 |
predicted gene, 25942 |
4748 |
0.17 |
chr1_42703489_42704501 | 14.15 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr9_18473066_18474201 | 14.14 |
Zfp558 |
zinc finger protein 558 |
74 |
0.95 |
chr13_83749344_83749514 | 13.52 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10566 |
0.12 |
chr5_73061669_73061857 | 12.61 |
Fryl |
FRY like transcription coactivator |
3470 |
0.18 |
chr18_54820930_54821296 | 12.27 |
Gm33732 |
predicted gene, 33732 |
2676 |
0.26 |
chr15_39828831_39829007 | 11.64 |
Dpys |
dihydropyrimidinase |
28548 |
0.17 |
chr13_83988136_83988456 | 11.62 |
Gm4241 |
predicted gene 4241 |
305 |
0.91 |
chr10_96955859_96956119 | 11.60 |
Gm33981 |
predicted gene, 33981 |
2882 |
0.33 |
chr17_69736615_69736970 | 11.20 |
Gm49895 |
predicted gene, 49895 |
39220 |
0.2 |
chr13_107540756_107541086 | 11.18 |
Gm32004 |
predicted gene, 32004 |
24402 |
0.2 |
chr3_50014297_50014449 | 11.16 |
Gm37854 |
predicted gene, 37854 |
12401 |
0.22 |
chr10_58227289_58228680 | 10.92 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr7_54633921_54634114 | 10.92 |
Gm6290 |
predicted gene 6290 |
22819 |
0.27 |
chr16_66969527_66969691 | 10.91 |
Cadm2 |
cell adhesion molecule 2 |
16275 |
0.28 |
chr5_4485578_4485761 | 10.76 |
Fzd1 |
frizzled class receptor 1 |
272366 |
0.01 |
chr12_49481243_49481456 | 10.70 |
1810007C17Rik |
RIKEN cDNA 1810007C17 gene |
487 |
0.8 |
chr2_101592129_101592615 | 10.59 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
7438 |
0.19 |
chr12_29530181_29530335 | 9.96 |
Gm20208 |
predicted gene, 20208 |
857 |
0.6 |
chr3_62455854_62456272 | 9.75 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
16524 |
0.23 |
chr9_40268412_40269319 | 9.66 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr14_93009566_93009910 | 9.65 |
Gm48963 |
predicted gene, 48963 |
117036 |
0.06 |
chr1_81077432_81077601 | 9.55 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
67 |
0.99 |
chr18_85939126_85939330 | 9.53 |
Gm5824 |
predicted gene 5824 |
90499 |
0.1 |
chr14_103764083_103764411 | 9.42 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
64805 |
0.11 |
chr9_91365711_91366045 | 9.21 |
Zic1 |
zinc finger protein of the cerebellum 1 |
68 |
0.95 |
chr4_124035183_124035559 | 9.17 |
Gm12902 |
predicted gene 12902 |
109137 |
0.05 |
chr12_49382570_49382928 | 9.06 |
Foxg1 |
forkhead box G1 |
51 |
0.93 |
chr5_110997258_110997442 | 8.87 |
Mir701 |
microRNA 701 |
6794 |
0.15 |
chr11_35798556_35798728 | 8.75 |
Fbll1 |
fibrillarin-like 1 |
242 |
0.9 |
chr2_45032656_45032807 | 8.72 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
9061 |
0.21 |
chr6_31948254_31948407 | 8.69 |
1700012A03Rik |
RIKEN cDNA 1700012A03 gene |
101916 |
0.07 |
chr14_76032657_76033188 | 8.66 |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
22057 |
0.18 |
chr4_32483032_32483200 | 8.63 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
18389 |
0.22 |
chr8_12947304_12948554 | 8.54 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chrX_88115590_88115759 | 8.53 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
29 |
0.99 |
chr7_64533404_64533751 | 8.53 |
Gm44721 |
predicted gene 44721 |
4152 |
0.22 |
chr8_58372581_58372772 | 8.49 |
Gm45635 |
predicted gene 45635 |
126089 |
0.06 |
chr18_8027073_8027284 | 8.45 |
Gm4833 |
predicted gene 4833 |
24025 |
0.22 |
chr3_17805299_17805450 | 8.43 |
Gm23441 |
predicted gene, 23441 |
1627 |
0.36 |
chr14_87338045_87338220 | 8.37 |
Gm23278 |
predicted gene, 23278 |
8113 |
0.25 |
chr2_85198006_85198625 | 8.31 |
Lrrc55 |
leucine rich repeat containing 55 |
1118 |
0.31 |
chr2_62294014_62294165 | 8.27 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
23301 |
0.2 |
chr5_112577448_112578314 | 8.24 |
Sez6l |
seizure related 6 homolog like |
696 |
0.62 |
chr6_5409080_5409263 | 8.23 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
18744 |
0.23 |
chr2_172699125_172699276 | 8.16 |
Tfap2c |
transcription factor AP-2, gamma |
147084 |
0.04 |
chr1_78167977_78168321 | 8.15 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chr1_176946812_176947011 | 8.13 |
Gm15423 |
predicted gene 15423 |
14200 |
0.13 |
chr17_13504900_13505090 | 8.12 |
Gm16050 |
predicted gene 16050 |
4041 |
0.14 |
chr13_29273638_29274140 | 8.10 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr1_42691969_42692512 | 8.06 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
853 |
0.48 |
chr12_88800772_88801300 | 7.99 |
Nrxn3 |
neurexin III |
5597 |
0.29 |
chr2_84887826_84888036 | 7.99 |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
1221 |
0.36 |
chr18_25677554_25677705 | 7.97 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
36141 |
0.19 |
chr1_25033599_25033750 | 7.95 |
Gm29414 |
predicted gene 29414 |
6442 |
0.21 |
chr14_80138884_80139035 | 7.93 |
Gm17923 |
predicted gene, 17923 |
75971 |
0.1 |
chr18_35215250_35215438 | 7.88 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
320 |
0.55 |
chr4_87229982_87230757 | 7.86 |
Slc24a2 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
53 |
0.99 |
chr4_54331579_54331820 | 7.85 |
Gm12469 |
predicted gene 12469 |
95823 |
0.08 |
chr13_84065521_84065798 | 7.76 |
Gm17750 |
predicted gene, 17750 |
887 |
0.64 |
chr14_64233595_64233767 | 7.74 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
117367 |
0.05 |
chr7_122477929_122478146 | 7.73 |
Gm14389 |
predicted gene 14389 |
6383 |
0.17 |
chr3_120729802_120729988 | 7.70 |
Gm42927 |
predicted gene 42927 |
9666 |
0.29 |
chr1_39838949_39839130 | 7.66 |
1700066B17Rik |
RIKEN cDNA 1700066B17 gene |
6660 |
0.21 |
chr10_118102987_118104071 | 7.64 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chr7_92316451_92316662 | 7.63 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
81429 |
0.09 |
chr3_118626529_118626766 | 7.60 |
Dpyd |
dihydropyrimidine dehydrogenase |
64461 |
0.11 |
chr13_19883955_19884185 | 7.58 |
Gpr141 |
G protein-coupled receptor 141 |
59813 |
0.12 |
chr4_63528950_63529291 | 7.58 |
Atp6v1g1 |
ATPase, H+ transporting, lysosomal V1 subunit G1 |
15652 |
0.12 |
chr4_13599724_13600127 | 7.57 |
Gm11825 |
predicted gene 11825 |
6109 |
0.25 |
chr3_83429511_83429671 | 7.56 |
Gm38096 |
predicted gene, 38096 |
26189 |
0.24 |
chr15_27937143_27937623 | 7.50 |
Trio |
triple functional domain (PTPRF interacting) |
18112 |
0.22 |
chr19_21494190_21494506 | 7.48 |
Gda |
guanine deaminase |
20903 |
0.22 |
chr13_54760412_54760681 | 7.38 |
Sncb |
synuclein, beta |
2521 |
0.17 |
chr3_16431647_16431999 | 7.38 |
Ythdf3 |
YTH N6-methyladenosine RNA binding protein 3 |
248587 |
0.02 |
chrX_151016523_151016902 | 7.37 |
Gnl3l |
guanine nucleotide binding protein-like 3 (nucleolar)-like |
610 |
0.7 |
chr6_51057202_51057641 | 7.37 |
Gm44402 |
predicted gene, 44402 |
90153 |
0.08 |
chr3_94466182_94466333 | 7.34 |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
6665 |
0.08 |
chr1_3094658_3094926 | 7.33 |
Gm26206 |
predicted gene, 26206 |
7224 |
0.25 |
chr19_33391464_33392505 | 7.32 |
Rnls |
renalase, FAD-dependent amine oxidase |
281 |
0.91 |
chr18_57262231_57262735 | 7.31 |
Gm50200 |
predicted gene, 50200 |
52657 |
0.11 |
chr3_134629851_134630075 | 7.30 |
Gm26820 |
predicted gene, 26820 |
802 |
0.76 |
chr16_85092305_85093056 | 7.24 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr13_78183985_78184266 | 7.23 |
Gm38604 |
predicted gene, 38604 |
957 |
0.45 |
chr6_73644786_73645257 | 7.22 |
Gm31747 |
predicted gene, 31747 |
36348 |
0.2 |
chr2_151967516_151967853 | 7.21 |
Mir1953 |
microRNA 1953 |
67 |
0.96 |
chr5_66862241_66862546 | 7.20 |
Gm6517 |
predicted gene 6517 |
27973 |
0.15 |
chr1_84890058_84890401 | 7.15 |
Fbxo36 |
F-box protein 36 |
21078 |
0.13 |
chr4_81567754_81568245 | 7.15 |
Gm11765 |
predicted gene 11765 |
106267 |
0.07 |
chr3_55248555_55248739 | 7.15 |
Dclk1 |
doublecortin-like kinase 1 |
1368 |
0.44 |
chr3_117752464_117752615 | 7.11 |
Snx7 |
sorting nexin 7 |
78735 |
0.1 |
chr1_165967105_165967280 | 7.06 |
Gm17976 |
predicted gene, 17976 |
25574 |
0.13 |
chr14_71963403_71963695 | 7.05 |
4930434J06Rik |
RIKEN cDNA 4930434J06 gene |
50458 |
0.18 |
chr2_74974713_74974872 | 7.04 |
n-R5s198 |
nuclear encoded rRNA 5S 198 |
39278 |
0.14 |
chr18_26161830_26162015 | 7.02 |
Gm33228 |
predicted gene, 33228 |
149619 |
0.05 |
chrX_95658622_95659031 | 7.02 |
Zc4h2 |
zinc finger, C4H2 domain containing |
317 |
0.9 |
chr4_55928738_55928923 | 7.00 |
Gm12519 |
predicted gene 12519 |
64909 |
0.14 |
chr2_115460480_115461045 | 6.99 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
51439 |
0.15 |
chr7_87111064_87111215 | 6.97 |
Gm44925 |
predicted gene 44925 |
7728 |
0.27 |
chr14_21251959_21252148 | 6.96 |
Adk |
adenosine kinase |
66072 |
0.12 |
chr4_82946256_82946439 | 6.95 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
5465 |
0.26 |
chr18_64266208_64266538 | 6.93 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
15 |
0.97 |
chr14_70659174_70659883 | 6.92 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr18_4785343_4785631 | 6.91 |
Gm10556 |
predicted gene 10556 |
26999 |
0.2 |
chr13_99284457_99284785 | 6.90 |
Ptcd2 |
pentatricopeptide repeat domain 2 |
60084 |
0.11 |
chr15_42309753_42309936 | 6.89 |
Gm49452 |
predicted gene, 49452 |
10502 |
0.2 |
chr8_125254170_125254832 | 6.88 |
Gm16237 |
predicted gene 16237 |
27178 |
0.23 |
chr19_15801056_15801381 | 6.88 |
Gm50348 |
predicted gene, 50348 |
1840 |
0.46 |
chr3_54965592_54965792 | 6.86 |
Sertm1 |
serine rich and transmembrane domain containing 1 |
49805 |
0.12 |
chr7_70103761_70103947 | 6.84 |
Gm35325 |
predicted gene, 35325 |
103581 |
0.06 |
chr12_16091538_16091689 | 6.82 |
Gm18114 |
predicted gene, 18114 |
63488 |
0.1 |
chr8_10794629_10794798 | 6.82 |
Rps16-ps3 |
ribosomal protein S16, pseudogene 3 |
14415 |
0.14 |
chr13_89030350_89030501 | 6.81 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
208783 |
0.03 |
chr8_32380698_32380864 | 6.80 |
Nrg1 |
neuregulin 1 |
87868 |
0.1 |
chr19_19886436_19886618 | 6.77 |
Gm50216 |
predicted gene, 50216 |
9964 |
0.3 |
chr3_56475903_56476451 | 6.73 |
Gm25727 |
predicted gene, 25727 |
30765 |
0.25 |
chr3_156633227_156633390 | 6.72 |
Gm42946 |
predicted gene 42946 |
13012 |
0.21 |
chr15_63768822_63768973 | 6.72 |
Gm46499 |
predicted gene, 46499 |
8736 |
0.12 |
chr8_18311041_18311326 | 6.69 |
1700014L14Rik |
RIKEN cDNA 1700014L14 gene |
23155 |
0.22 |
chr15_86689893_86690044 | 6.67 |
Gm49464 |
predicted gene, 49464 |
14323 |
0.21 |
chr16_9753013_9753397 | 6.65 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
44128 |
0.2 |
chr1_57083188_57083527 | 6.65 |
9130024F11Rik |
RIKEN cDNA 9130024F11 gene |
42964 |
0.14 |
chr6_136172729_136173004 | 6.64 |
Gm26653 |
predicted gene, 26653 |
195 |
0.58 |
chr13_41759205_41759377 | 6.63 |
Adtrp |
androgen dependent TFPI regulating protein |
41275 |
0.13 |
chr13_83739197_83739995 | 6.60 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr5_84848501_84849167 | 6.56 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr6_52894578_52894779 | 6.55 |
Jazf1 |
JAZF zinc finger 1 |
14942 |
0.21 |
chr9_15421773_15422369 | 6.55 |
Gm2517 |
predicted gene 2517 |
2543 |
0.17 |
chr9_41586209_41586579 | 6.55 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1375 |
0.27 |
chr9_103147188_103147360 | 6.54 |
Gm37166 |
predicted gene, 37166 |
26906 |
0.13 |
chr13_64745464_64745703 | 6.54 |
Cntnap3 |
contactin associated protein-like 3 |
12878 |
0.17 |
chr13_84064676_84065083 | 6.54 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr1_54556878_54557293 | 6.52 |
Pgap1 |
post-GPI attachment to proteins 1 |
542 |
0.76 |
chr18_14844907_14845090 | 6.50 |
Gm21055 |
predicted gene, 21055 |
14330 |
0.21 |
chr16_67611348_67611518 | 6.50 |
Cadm2 |
cell adhesion molecule 2 |
9060 |
0.25 |
chr16_77238271_77238422 | 6.49 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2027 |
0.39 |
chr11_40469423_40469613 | 6.48 |
3110004A20Rik |
RIKEN cDNA 3110004A20 gene |
6159 |
0.2 |
chr16_3233110_3233980 | 6.47 |
Gm23215 |
predicted gene, 23215 |
16039 |
0.17 |
chr13_57937555_57937706 | 6.46 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
29298 |
0.21 |
chr5_109556763_109557843 | 6.46 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr7_40825372_40825735 | 6.46 |
Gm45008 |
predicted gene 45008 |
4443 |
0.2 |
chr2_57378479_57378900 | 6.41 |
Gm13531 |
predicted gene 13531 |
47020 |
0.16 |
chr13_84064376_84064611 | 6.40 |
Gm17750 |
predicted gene, 17750 |
279 |
0.93 |
chr7_44593726_44594565 | 6.36 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
150 |
0.87 |
chr2_51087621_51088075 | 6.35 |
Rnd3 |
Rho family GTPase 3 |
61246 |
0.13 |
chr1_57387961_57388154 | 6.34 |
Tyw5 |
tRNA-yW synthesizing protein 5 |
2714 |
0.19 |
chr16_77536418_77536599 | 6.33 |
Gm36963 |
predicted gene, 36963 |
3374 |
0.16 |
chr5_9623115_9623489 | 6.30 |
Gm42455 |
predicted gene 42455 |
20695 |
0.24 |
chr10_13107920_13108404 | 6.27 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
5303 |
0.23 |
chr11_42419537_42420113 | 6.26 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
61 |
0.99 |
chr12_49400589_49400976 | 6.25 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
10123 |
0.13 |
chr4_12263404_12263560 | 6.24 |
Gm11846 |
predicted gene 11846 |
7917 |
0.21 |
chr5_88583308_88583633 | 6.24 |
Rufy3 |
RUN and FYVE domain containing 3 |
43 |
0.97 |
chr12_45711385_45711536 | 6.23 |
Gm48522 |
predicted gene, 48522 |
25441 |
0.22 |
chr15_59040434_59041094 | 6.22 |
Mtss1 |
MTSS I-BAR domain containing 1 |
167 |
0.96 |
chr12_79911112_79911786 | 6.20 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
13284 |
0.2 |
chr3_80207799_80207950 | 6.20 |
Gm37892 |
predicted gene, 37892 |
2276 |
0.32 |
chr2_158588848_158589178 | 6.18 |
Gm14204 |
predicted gene 14204 |
21577 |
0.11 |
chr3_68824497_68825036 | 6.18 |
Gm7270 |
predicted gene 7270 |
21313 |
0.12 |
chr3_40094252_40094403 | 6.16 |
Gm42785 |
predicted gene 42785 |
270750 |
0.01 |
chr14_14070993_14071228 | 6.12 |
Atxn7 |
ataxin 7 |
16359 |
0.17 |
chr12_50193566_50193717 | 6.11 |
Gm40418 |
predicted gene, 40418 |
73332 |
0.13 |
chr1_9601126_9601277 | 6.09 |
Vxn |
vexin |
2 |
0.97 |
chr5_79300111_79300262 | 6.09 |
Gm43234 |
predicted gene 43234 |
140011 |
0.05 |
chr5_111843170_111843321 | 6.08 |
Gm36535 |
predicted gene, 36535 |
49858 |
0.13 |
chr13_79697994_79698288 | 6.08 |
Gm48471 |
predicted gene, 48471 |
139936 |
0.05 |
chrX_12858367_12858766 | 6.05 |
Gm25063 |
predicted gene, 25063 |
11796 |
0.19 |
chr5_111843996_111844162 | 6.03 |
Gm36535 |
predicted gene, 36535 |
50692 |
0.13 |
chr17_69230154_69230351 | 6.03 |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
13384 |
0.22 |
chr4_22491895_22492228 | 6.02 |
Gm30731 |
predicted gene, 30731 |
1513 |
0.34 |
chr9_41890642_41891131 | 6.02 |
Gm40513 |
predicted gene, 40513 |
282 |
0.9 |
chr15_41672291_41672462 | 6.01 |
Oxr1 |
oxidation resistance 1 |
38228 |
0.21 |
chr7_116736401_116736714 | 6.00 |
Gm25423 |
predicted gene, 25423 |
45072 |
0.15 |
chr3_34659165_34659316 | 6.00 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
3204 |
0.14 |
chr4_47899641_47899985 | 5.99 |
Gm22670 |
predicted gene, 22670 |
20942 |
0.2 |
chr15_76520651_76521002 | 5.99 |
Scrt1 |
scratch family zinc finger 1 |
1076 |
0.25 |
chr12_12877548_12878341 | 5.98 |
Gm48187 |
predicted gene, 48187 |
12374 |
0.14 |
chr18_45008774_45008950 | 5.96 |
Gm31706 |
predicted gene, 31706 |
36000 |
0.15 |
chr5_89763498_89763843 | 5.95 |
Gm25758 |
predicted gene, 25758 |
65201 |
0.13 |
chr6_22205459_22205620 | 5.94 |
Gm42573 |
predicted gene 42573 |
40395 |
0.17 |
chr18_34561522_34561725 | 5.92 |
Nme5 |
NME/NM23 family member 5 |
17460 |
0.12 |
chrX_7721605_7722047 | 5.92 |
Wdr45 |
WD repeat domain 45 |
147 |
0.74 |
chr13_83884272_83884423 | 5.89 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
6861 |
0.22 |
chr16_7149584_7149774 | 5.88 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
44068 |
0.22 |
chr9_37076724_37076963 | 5.88 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
6436 |
0.17 |
chr4_23513963_23514189 | 5.87 |
Gm11889 |
predicted gene 11889 |
4364 |
0.28 |
chr13_8567482_8568009 | 5.87 |
Gm48262 |
predicted gene, 48262 |
14725 |
0.26 |
chr9_25378508_25378723 | 5.87 |
Gm18891 |
predicted gene, 18891 |
29117 |
0.17 |
chr6_36723290_36723453 | 5.87 |
Gm25111 |
predicted gene, 25111 |
23974 |
0.22 |
chr13_71507941_71508418 | 5.86 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr11_32157683_32158170 | 5.85 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr11_54754283_54754711 | 5.85 |
Cdc42se2 |
CDC42 small effector 2 |
5842 |
0.15 |
chr5_83593274_83593496 | 5.85 |
Gm25765 |
predicted gene, 25765 |
55569 |
0.15 |
chr8_86324726_86324877 | 5.85 |
Gm24490 |
predicted gene, 24490 |
32300 |
0.21 |
chr2_22029338_22029851 | 5.83 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
chr8_122804269_122804471 | 5.83 |
Gm45743 |
predicted gene 45743 |
21716 |
0.09 |
chr19_59044212_59044389 | 5.83 |
Shtn1 |
shootin 1 |
6015 |
0.22 |
chr8_7721993_7722144 | 5.82 |
Gm25169 |
predicted gene, 25169 |
83304 |
0.1 |
chr11_41532088_41532404 | 5.81 |
Hspd1-ps3 |
heat shock protein 1 (chaperonin), pseudogene 3 |
33509 |
0.2 |
chr18_19604217_19604405 | 5.81 |
Gm7720 |
predicted gene 7720 |
49351 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.0 | 20.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
3.5 | 10.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
3.4 | 6.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
3.3 | 13.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.7 | 8.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
2.6 | 10.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.4 | 7.2 | GO:0097503 | sialylation(GO:0097503) |
2.2 | 13.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
2.2 | 8.7 | GO:0030035 | microspike assembly(GO:0030035) |
2.1 | 8.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.0 | 5.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.9 | 5.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.8 | 5.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.8 | 12.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.8 | 5.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.8 | 7.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.6 | 4.7 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.5 | 3.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.5 | 10.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.4 | 4.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.4 | 12.7 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.4 | 4.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.4 | 12.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.4 | 1.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.3 | 2.7 | GO:0061055 | myotome development(GO:0061055) |
1.3 | 1.3 | GO:0046958 | nonassociative learning(GO:0046958) |
1.3 | 3.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.3 | 5.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.3 | 5.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.2 | 4.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.2 | 3.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.2 | 7.2 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.2 | 6.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.2 | 3.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.2 | 3.6 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.2 | 4.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.2 | 3.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.1 | 4.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.1 | 3.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.1 | 3.4 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 4.5 | GO:0060459 | left lung development(GO:0060459) |
1.1 | 5.6 | GO:0033762 | response to glucagon(GO:0033762) |
1.1 | 5.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.1 | 3.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.1 | 3.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.1 | 3.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.1 | 5.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.1 | 2.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.0 | 4.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.0 | 8.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.0 | 3.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.0 | 20.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.0 | 4.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.0 | 3.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 4.9 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 2.9 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.0 | 1.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.0 | 1.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.9 | 2.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.9 | 4.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.9 | 2.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.9 | 2.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 0.9 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.9 | 6.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.9 | 10.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.9 | 1.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 4.3 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.9 | 6.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.8 | 1.7 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.8 | 2.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.8 | 2.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.8 | 4.9 | GO:0022605 | oogenesis stage(GO:0022605) |
0.8 | 18.9 | GO:0035640 | exploration behavior(GO:0035640) |
0.8 | 3.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.8 | 2.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.8 | 1.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 3.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.8 | 3.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 1.6 | GO:0014029 | neural crest formation(GO:0014029) |
0.8 | 2.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.8 | 2.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.8 | 0.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.8 | 5.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.7 | 3.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.7 | 2.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.7 | 1.5 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.7 | 2.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.7 | 2.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.7 | 1.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.7 | 2.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.7 | 4.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.7 | 2.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 0.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.7 | 2.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 11.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 2.1 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.7 | 2.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.7 | 2.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.7 | 2.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.7 | 0.7 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.7 | 3.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 4.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.7 | 6.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.6 | 1.3 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.6 | 1.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 1.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 2.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 12.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.6 | 1.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 1.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 2.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 3.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 1.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.6 | 0.6 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.6 | 1.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.6 | 4.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.6 | 2.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.6 | 1.8 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.6 | 1.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 1.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 6.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 | 0.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.6 | 2.9 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.6 | 0.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.6 | 1.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 1.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 8.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.6 | 2.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 4.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 3.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 3.2 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.5 | 3.2 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.5 | 3.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 1.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 1.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.5 | 3.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.5 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 2.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 1.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 0.5 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.5 | 2.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 1.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 2.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 4.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.5 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.5 | 1.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 2.0 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.5 | 1.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.5 | 5.0 | GO:0001964 | startle response(GO:0001964) |
0.5 | 5.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 2.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.5 | 1.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.5 | 2.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 1.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 4.8 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.5 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.5 | 1.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 1.9 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 1.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 1.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 1.4 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 1.9 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.5 | 2.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 0.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.5 | 2.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.5 | 7.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.5 | 1.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 0.5 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.4 | 4.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.4 | 2.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 3.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 0.9 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.4 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 1.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 2.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 0.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 2.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.4 | 0.8 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.4 | 2.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.4 | 1.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.4 | 4.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 0.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 2.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 1.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 1.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 0.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 0.8 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 1.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.4 | 1.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 9.2 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 1.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 31.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.8 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.4 | 1.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 0.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.4 | 0.4 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 2.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 2.0 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 1.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 1.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.4 | 1.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 0.8 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 0.4 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.4 | 1.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.4 | 1.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 1.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 1.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.4 | 1.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 2.7 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 1.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 1.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 16.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 1.1 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 1.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 0.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.4 | 3.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 1.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.4 | 0.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 0.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 1.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 5.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 1.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 3.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.7 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 2.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 2.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.3 | 0.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 3.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 2.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 0.7 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 2.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 1.6 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 7.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 0.6 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.3 | 1.6 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 3.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 3.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 1.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 3.4 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.3 | 0.6 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.3 | 1.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 1.9 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.3 | 2.2 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.3 | 1.8 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 0.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.6 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.3 | 0.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.3 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 0.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 1.8 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 0.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 0.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.9 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.3 | 0.6 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 2.0 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 0.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 0.8 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 2.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 1.4 | GO:0038001 | paracrine signaling(GO:0038001) |
0.3 | 1.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.3 | 3.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 2.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.8 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.3 | 1.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 0.5 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 0.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 2.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 1.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 1.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 0.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.5 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.2 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.7 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 1.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 1.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.5 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 0.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.7 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.4 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.2 | 2.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 4.8 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 0.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 3.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 1.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 4.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 2.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 1.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 1.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 1.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 1.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.9 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.2 | 0.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 1.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 1.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 3.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) nucleoside salvage(GO:0043174) |
0.2 | 1.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 2.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.7 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.3 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.5 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.2 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.7 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.2 | 0.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.8 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.5 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.5 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.2 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 1.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 4.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 1.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.6 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 1.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 1.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 1.6 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.6 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 6.6 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 3.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.7 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.8 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 2.1 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.1 | 0.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.4 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.4 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.2 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 1.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 1.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 2.6 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 1.6 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.7 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 1.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.2 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.4 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.4 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.7 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.2 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.2 | GO:2000172 | branching morphogenesis of a nerve(GO:0048755) regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.2 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.8 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.1 | 0.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 1.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.2 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.2 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 1.6 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 1.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.7 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.1 | GO:0003160 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.2 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.4 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 1.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.6 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.3 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.0 | 0.0 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.9 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:0070572 | regulation of neuron projection regeneration(GO:0070570) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.8 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.0 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.0 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.0 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.0 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.1 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.0 | 0.0 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.0 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 25.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.5 | 17.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.8 | 5.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.7 | 13.6 | GO:0071437 | invadopodium(GO:0071437) |
1.6 | 4.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.6 | 8.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 4.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.4 | 2.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.4 | 5.6 | GO:0033269 | internode region of axon(GO:0033269) |
1.4 | 6.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.4 | 4.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.4 | 4.1 | GO:0097441 | basilar dendrite(GO:0097441) |
1.3 | 4.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.2 | 10.0 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 1.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.2 | 7.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.1 | 3.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.1 | 9.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.1 | 7.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.9 | 4.6 | GO:0097433 | dense body(GO:0097433) |
0.9 | 3.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.9 | 15.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 9.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.8 | 2.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.8 | 3.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 6.2 | GO:0016342 | catenin complex(GO:0016342) |
0.8 | 2.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 2.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 2.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 2.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.7 | 16.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.7 | 6.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 17.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 2.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.7 | 26.0 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.7 | 9.1 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 4.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.6 | 5.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 1.6 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 1.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 1.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.5 | 1.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 0.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.5 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 12.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 7.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 1.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 1.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 9.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 4.5 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 12.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 2.0 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 2.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 53.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 3.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 4.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.3 | 9.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 2.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 2.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 0.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 1.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 1.8 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.2 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 3.4 | GO:0043205 | fibril(GO:0043205) |
0.2 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 4.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 1.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 1.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 2.0 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 8.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 3.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 2.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 14.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 5.1 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 4.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 6.2 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.7 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 1.2 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 2.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 1.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 3.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.3 | GO:0071012 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 2.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.4 | 12.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.3 | 11.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.1 | 10.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.1 | 6.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.1 | 8.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.1 | 8.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.9 | 11.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.9 | 5.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.9 | 5.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.6 | 7.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.5 | 12.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.5 | 3.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.3 | 3.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.3 | 3.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.2 | 5.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.2 | 3.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.2 | 3.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.2 | 8.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.2 | 5.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 6.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.1 | 1.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.1 | 4.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.0 | 3.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.0 | 7.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.0 | 4.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 3.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.0 | 2.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.0 | 12.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 9.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.8 | 2.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.8 | 3.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.8 | 3.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.7 | 2.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.7 | 1.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 3.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 1.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.7 | 3.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.7 | 2.0 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 4.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 3.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.7 | 2.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 5.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 1.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 1.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 1.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.6 | 2.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.6 | 4.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.6 | 1.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 19.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 2.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 4.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 1.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 1.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 2.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 5.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 2.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 1.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 1.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 1.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 2.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 1.5 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 1.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 14.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.5 | 1.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 5.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 4.1 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 4.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.4 | 1.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 1.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 1.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 1.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.4 | 2.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 2.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 1.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 8.7 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 5.0 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 1.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 14.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 1.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 2.6 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 7.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 3.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 3.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 1.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 4.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 1.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 1.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 1.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 3.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 6.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 4.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 3.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 2.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 1.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 3.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 4.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 7.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 0.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 3.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 5.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 5.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 2.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 0.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 0.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 3.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 0.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.2 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 3.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 7.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.7 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 4.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 3.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 1.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 2.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 2.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 6.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.4 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.4 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 1.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 2.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 5.4 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 8.4 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 2.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 2.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 3.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.6 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.6 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 4.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.9 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.6 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 3.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 2.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 1.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 4.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 2.2 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 1.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.5 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.5 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0099528 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 2.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.5 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 7.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 4.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 8.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 5.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 6.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 4.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 4.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 6.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 2.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 3.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 3.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 17.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.5 | 20.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.3 | 30.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.0 | 15.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.0 | 3.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 5.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 7.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 7.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 25.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 5.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 9.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 6.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 6.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 1.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 4.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 0.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 4.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 3.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 7.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 4.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 5.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 2.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 2.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 2.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.3 | 11.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 4.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 4.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 0.7 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.2 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 2.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 3.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 4.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 4.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 1.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 5.6 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 1.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 0.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.2 | 2.6 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 4.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 3.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 2.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 5.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |